MBX Biosciences (NASDAQ:MBX) Bolsa, Quote.MetaTitle.unusual-options

MBX Biosciences

MBX Biosciences Inc

MICROBIX BIOSYSTEMS INC by Microbix Biosystems Inc.

Microbix Biosystems Inc

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

Cormedix

Cronos Group

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

GH Research

Harrow

LENZ Therapeutics

Mind Medicine (MindMed) Inc. - Common Shares

Mind Medicine

Nektar Therapeutics

Oculis Holding

Pacira BioSciences

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Tilray Brands

Trevi Therapeutics

Ventyx Biosciences

Wave Life Sciences Ltd. - Ordinary Shares

WAVE Life Sciences

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings

MBX Biosciences (MBX) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Comments

MBX Biosciences Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL